5 Stocks to Watch: Week of 4/20/2026
We’ve got a great list of stocks to watch in the coming week. What do they have in common? Excellent Zen Ratings and deep admiration from Wall Street's brightest and best. Let's go:
- Levi Strauss & Co. (LEVI) — DTC transformation driving perfect analyst consensus
- SanDisk Corp (SNDK) — Up 2,200% in a year riding the AI wave
- Gilead Sciences Inc (GILD) — Top-rated pharma giant with a $5B oncology bet
- Kinross Gold Corp (KGC) — Up 126% and analysts still see more upside
- Q2 Holdings Inc (QTWO) — Digital banking pioneer with 254% earnings growth ahead
A note from our sponsors...
Buffett's $114 Secret In 1943, a teenage Warren Buffett put $114 into a special type of account called "The 29% Account." Today, that single, $114 investment would be worth over $15 million. Your bank never told you about this. Click Here to See How It Works1- Q2 Holdings Inc (NYSE: QTWO)
Digital banking is evolving fast — and Q2 Holdings is helping lead the charge. This Austin-based fintech just partnered with Stablecore to bring stablecoins and digital assets to community banks and credit unions, planting its flag at the cutting edge of where finance is headed next.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $51.01 — get current quote
Max 1-year forecast: $82.00
Why we're watching:
- Analyst support: Q2 Holdings garners strong backing from 7 analysts with 4 Strong Buy ratings, 2 Buy ratings, and 1 Hold rating, achieving a Strong Buy consensus. See the ratings
- DA Davidson's Peter Heckmann (a top 10% rated analyst) recently upgraded Q2 to Strong Buy with an $82.00 price target, signaling over 63% upside potential and a strong conviction in the company's digital banking platform and growth prospects following strong execution.
- Overall, analysts project impressive earnings growth with EPS forecast to reach $2.98 in one year (up 254.7%) and $3.49 in two years, demonstrating strong profitability trajectory as the company scales its SaaS platform.
- Industry ranking context: QTWO is currently the #9 highest-rated stock in the App industry, which has an Industry Rating of B.
- Zen Rating highlights: Q2 earns a coveted A Zen Rating, putting it in the top 5% of stocks we track based on a rigorous 115-factor review. This elite tier of stocks has historically delivered over 30% returns annually.
- Component Grades: Each Zen Rating is composed of 7 Component Grades. Q2 showcases exceptional potential with A grades in Growth and AI alongside B grades in Sentiment and Financials, positioning it as a leader in the digital banking transformation. See all 7 Zen Component Grades here
2- Levi Strauss & Co. (NYSE: LEVI)
Levi Strauss designs, markets, and sells jeans and casual wear globally — but this isn't your grandfather's denim company. Levi's is transforming into a direct-to-consumer lifestyle brand, with DTC sales now exceeding 50% of total revenue and driving impressive growth.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $22.21 — get current quote
Max 1-year forecast: $34.00
Why we're watching:
- Analyst support: A perfect consensus with 2 Strong Buy and 3 Buy ratings among 5 analysts, with zero Hold, Sell, or Strong Sell ratings. See the ratings
- UBS researcher Jay Sole (a top 6% rated analyst) recently raised the price target to $34 (suggesting nearly 50% potential upside) following Q1 2026 earnings, noting the company's transformation into a global, multi-channel lifestyle brand will support mid-single-digit revenue growth with mid-teens percentage margins over time.
- Industry ranking context: LEVI is currently the 1st highest-rated stock in the Apparel Manufacturing industry, which has an Industry Rating of A.
- Zen Rating highlights: LEVI earns its place among the best-rated stocks in our 4600+ stock database — the company's transformation strategy is delivering results with DTC revenues up 16% year-over-year.
- Component Grades: LEVI earns an impressive A for Sentiment, Bs for Value, Growth, Safety, and Financials, and Cs for Momentum and Artificial Intelligence. See all 7 Zen Component Grades here
A note from our sponsors...
Buffett's $114 Secret In 1943, a teenage Warren Buffett put $114 into a special type of account called "The 29% Account." Today, that single, $114 investment would be worth over $15 million. Your bank never told you about this. Click Here to See How It Works3- SanDisk Corp (NASDAQ: SNDK)
SanDisk develops storage devices and solutions built on NAND flash technology, from solid state drives to embedded and removable storage. The stock has skyrocketed over 2,200% in the past year as the AI boom fuels massive demand for memory solutions — and it's about to join the Nasdaq-100 Index on April 20, 2026.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $913.03 — get current quote
Max 1-year forecast: $1,200.00
Why we're watching:
- Analyst support: SNDK enjoys strong Wall Street backing with 9 Strong Buy ratings, 4 Buy ratings, and 4 Hold ratings among 17 analysts, delivering a Strong Buy consensus. See the ratings
- Cantor Fitzgerald's C.J. Muse (a top 2% rated analyst) recently maintained a Strong Buy rating with a $1,000 price target, representing 12% upside even after the massive rally.
- Bank of America's Wamsi Mohan (top 1%) set a $900 price target, while Citigroup's Asiya Merchant (top 1%) targeted $980, both maintaining Strong Buy ratings.
- Morgan Stanley's Joseph Moore (top 1%) and Jefferies' Blayne Curtis (top 2%) both highlighted the company's position as a pure-play NAND winner in the AI boom.
- SNDK is also part of our Zen Investor portfolio, where Editor-in-Chief Steve Reitmeister still rates SNDK a Strong Buy despite the fact that it’s already gained 70% since its addition to the portfolio. See more of the stocks in the portfolio here.
- Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr, putting SNDK in the top tier of stocks we track based on a 115-factor review.
- Component Grades: Looking at the Component Grades that shape the overall rating, SNDK earns an impressive A for Growth, Bs for Momentum, Sentiment, and Financials, and Cs for Value, Safety, and Artificial Intelligence — reflecting the company's exceptional growth trajectory balanced against its rapid valuation expansion. See all 7 Zen Component Grades here
4- Kinross Gold Corp (NYSE: KGC)
Up 126% in a year and analysts say there's still room to run. Kinross is a global gold and silver miner operating across six countries, and with economic uncertainty fueling demand for precious metals, this stock has become one of Wall Street's favorite ways to play the gold trade.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $33.87 — get current quote
Max 1-year forecast: $45.00
Why we're watching:
- KGC was previously part of our Zen Investor portfolio — Editor-in-Chief Steve Reitmeister issued a Sell rating once it had gained over 140%. (See the rest of the stocks in the portfolio here). But it’s baaack… Here’s why.
- First, let’s dig into analyst support. Kinross enjoys unanimous bullish sentiment from 4 analysts with 1 Strong Buy and 3 Buy ratings, achieving a Strong Buy consensus. See the ratings
- ScotiaBank's Tanya Jakusconek (a top 6% rated analyst) recently maintained a Buy rating with an ambitious price target suggesting over 34% potential upside, reflecting strong conviction in Kinross's ability to capitalize on favorable gold market dynamics.
- Industry ranking context: KGC is currently the #7 highest-rated stock in the Gold industry, which has an Industry Rating of A. (See more excellent mining stocks in this video.)
- Zen Rating highlights: A (Strong Buy) stocks average +32.52%/yr — Kinross combines this elite rating with an outstanding Financials grade of A, supported by a 44.8% profit margin and strong cash flow generation.
- Component Grades: The company demonstrates exceptional financial health with an A in Financials alongside B grades in Value and Momentum, reflecting both operational excellence and market momentum in the precious metals sector. See all 7 Zen Component Grades here
5- Gilead Sciences Inc (NASDAQ: GILD)
Gilead Sciences is a leading biopharma company behind some of the most important HIV and hepatitis treatments worldwide. Now, it's making a bold push into oncology with a $5B Tubulis acquisition — signaling a major new growth chapter ahead.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $138.78 — get current quote
Max 1-year forecast: $180.00
Why we're watching:
- Analyst support: GILD enjoys impressive coverage with 10 Strong Buy ratings, 2 Buy ratings, and 2 Hold ratings among 14 analysts we track, reflecting strong confidence in the company's direction. See the ratings
- Needham's Joseph Stringer (a top 1% rated analyst) reiterated a Buy rating with a $170 price target (suggesting over 20% potential upside), highlighting the company's robust pipeline and effective strategy.
- Industry ranking context: GILD is currently the 1st highest-rated stock in the General Drug Manufacturer industry, which has an Industry Rating of A. (Learn more about our Industry Ranking here.)
- Zen Rating highlights: As a Strong Buy stock, GILD ranks in the top 5% of tickers we track based on a sturdy 115-factor review.
- Component Grades: Looking at the Component Grades that make up that overall score, GILD earns impressive As for Value and Financials, a B for Momentum and Safety, and Cs for Growth, Sentiment, and Artificial Intelligence. See all 7 Zen Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.